|
BTG3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.481210E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.178500E-03 |
| Normal-vs-Stage2 |
2.352600E-04 |
| Normal-vs-Stage3 |
1.997660E-03 |
| Normal-vs-Stage4 |
4.527400E-01 |
| Stage1-vs-Stage2 |
2.054400E-01 |
| Stage1-vs-Stage3 |
5.041200E-01 |
| Stage1-vs-Stage4 |
2.883800E-01 |
| Stage2-vs-Stage3 |
5.193600E-01 |
| Stage2-vs-Stage4 |
5.669800E-02 |
| Stage3-vs-Stage4 |
1.605770E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.681300E-03 |
| Normal-vs-AfricanAmerican |
8.042100E-03 |
| Normal-vs-Asian |
3.850300E-02 |
| Caucasian-vs-AfricanAmerican |
8.011400E-01 |
| Caucasian-vs-Asian |
7.514600E-01 |
| AfricanAmerican-vs-Asian |
5.230200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.424700E-03 |
| Normal-vs-Female |
1.049650E-02 |
| Male-vs-Female |
9.247600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.562280E-02 |
| Normal-vs-Extreme_Weight |
1.683370E-01 |
| Normal-vs-Obese |
7.895500E-03 |
| Normal-vs-Extreme_Obese |
1.062630E-03 |
| Normal_Weight-vs-Extreme_Weight |
4.982200E-01 |
| Normal_Weight-vs-Obese |
9.548200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.138600E-01 |
| Extreme_Weight-vs-Obese |
4.931800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.065700E-02 |
| Obese-vs-Extreme_Obese |
1.564600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.513400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.276800E-03 |
| Normal-vs-Age(61-80Yrs) |
8.578400E-03 |
| Normal-vs-Age(81-100Yrs) |
2.215700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.516000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.324200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.839600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.604000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.025800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.711400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.739200E-03 |
| Normal-VS-Type2 PRCC |
1.32289999954516E-07 |
| Normal-VS-KIRP CIMP |
3.345700E-02 |
| Normal-VS-Unclassified PRCC |
1.83706999999922E-05 |
| Type1 PRCC-VS-Type2 PRCC |
2.957100E-04 |
| Type1 PRCC-VS-KIRP CIMP |
3.568000E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
3.223700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.11870000041314E-07 |
| Type2 PRCC-VS-Unclassified PRCC |
5.035800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.91969999960595E-07 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.41899997202688E-09 |
| Normal-vs-N1 |
3.926200E-02 |
| Normal-vs-N2 |
7.012200E-01 |
| N0-vs-N1 |
2.763800E-02 |
| N0-vs-N2 |
7.781800E-04 |
| N1-vs-N2 |
2.171600E-01 |
|
|
